Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Stem Cell Culture01:17

Stem Cell Culture

5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Exposure prediction and dose optimization of polymyxin B based on bayesian and machine learning.

Frontiers in pharmacology·2026
Same author

Developmental regulation of kinetochore phosphorylation determines mitotic fidelity.

bioRxiv : the preprint server for biology·2026
Same author

LRP11 as a potential predictor of poor prognosis and immune suppression in lung adenocarcinoma.

Discover oncology·2025
Same author

Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes.

Clinical pharmacokinetics·2025
Same author

Analysis of clinical characteristics and laboratory examination data of 112 cases of Mycoplasma pneumoniae pneumonia in children.

Medicine·2025
Same author

Cyclin A/Cdk1 promotes chromosome alignment and timely mitotic progression.

Molecular biology of the cell·2024

相关实验视频

Updated: Jun 14, 2025

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
09:07

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

9.9K

细胞竞争消除了人类多能干细胞的干细胞.

Amanda Ya1, Chenhui Deng1, Kristina M Godek1

  • 1Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

Stem cell reports
|May 23, 2025
PubMed
概括

人类多能干细胞 (hPSCs) 通过细胞竞争来预防体积,而不是均消除. 具有不同MYC和p53水平的邻近细胞驱动这种基因组稳定机制.

科学领域:

  • 细胞生物学 细胞生物学
  • 发展生物学 发展生物学
  • 遗传学 遗传学 是一个

背景情况:

  • 人类多能干细胞 (hPSCs) 能够在几代人中保持双倍体质,尽管常见的线粒体错误导致了无倍体质.
  • 防止无体hPSCs传播和保持基因组稳定性的机制尚未完全理解.

研究的目的:

  • 研究如何在人类多能干细胞 (hPSCs) 中保持基因组稳定,尽管存在频繁的线粒错误.
  • 阐明在hPSC种群中消除无体细胞的基础机制.

主要方法:

  • 对hPSCs的均无体与马赛克群体进行比较分析.
  • 研究MYC和p53在细胞竞争动态中的作用.
  • 对二倍体和倍体hPSC之间的细胞非自主竞争的评估.

主要成果:

  • 与体细胞不同的是,具有多种异常核型的均无体hPSC种群可以繁殖.
  • 在马赛克群体中,细胞非自主竞争消除了不太适合的形hPSCs.
  • MYC和p53水平的相对丰富性决定了形细胞的竞争优势或劣势.

结论:

  • 由MYC和p53驱动的细胞竞争机制在hPSC中保持基因组完整性,尽管它们的线粒体忠实度较低.
关键词:
我的世界 MYC没有积症.细胞竞争 细胞竞争人类多能干细胞干细胞马赛克主义的马赛克主义.在 p53 里,p53 是一个 p53 的类型.在植入前的胚胎.

更多相关视频

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.2K
Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis
08:27

Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis

Published on: July 24, 2014

12.3K

相关实验视频

Last Updated: Jun 14, 2025

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
09:07

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

9.9K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.2K
Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis
08:27

Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis

Published on: July 24, 2014

12.3K
  • 这些发现对于hPSCs在再生医学中的安全应用至关重要.
  • 了解这一过程,可以了解人类胚胎在发育过程中的二倍体胚胎形成.